Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1453 of 5804
-
Light on the forehead: a new hope for depression?
Symptom relief Recruiting nowThe purpose of this research study is to determine if application of near infrared energy to the forehead can change blood flow in the brains of people with depression. Near infrared energy is like light but is not visible to the human eye.
Phase: NA • Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Heat waves for bladder relief? radiofrequency shows promise for overactive bladder
Symptom relief CompletedA prospective, randomized, single-blind, placebo-controlled study was conducted from June 2023 to May 2025. The study enrolled 95 women (N=48 in the study group; N=47 in the placebo group) who presented with confirmed symptoms of OAB and UUI prior to enrollment. Symptom severity …
Phase: NA • Sponsor: University Maribor • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Could a tiny dose of thyroid hormone heal fatty liver disease?
Disease control Recruiting nowNonalcoholic steatohepatitis (NASH) is the aggressive form of nonalcoholic fatty liver disease, which is rapidly becoming a worldwide public health problem. It is more common in the military and Veteran population compared to the general US population. NASH may progress to end-st…
Phase: PHASE2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Gentle movement therapy may help preterm babies at risk of cerebral palsy
Disease control OngoingBackground: Very preterm babies are at high risk for developmental disorders. Prechtl's General Movements (GMs) Assessment is a valuable and reliable tool in infants until three months corrected age for predicting their further developmental difficulties, particularly cerebral pa…
Phase: NA • Sponsor: University of Zurich • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New study seeks to uncover hidden causes of cardiac arrest
Knowledge-focused OngoingManagement of the reversible causes in cardiac arrest is fundamental for successful treatment of out-of-hospital cardiac arrests. Point-of-care diagnostics as prehospital emergency ultrasound, blood gas analysis and toxicological screening support the diagnostic process of evalua…
Phase: NA • Sponsor: Medical University of Vienna • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC
-
Could a common diabetes drug ease fibromyalgia pain?
Symptom relief Recruiting nowThe main purpose of the project is to evaluate the safety and efficacy of low dose metformin for improving symptoms associated with fibromyalgia syndrome (FMS) via modulating neuroinflammatory pathways. The investigators hypothesize that FMS patients in the low-dose metformin con…
Phase: PHASE2 • Sponsor: University of Utah • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Could a longer course of vaginal progesterone cut preterm births in IVF?
Prevention Recruiting nowTo investigate the incidence of preterm birth in IVF fresh embryo transplantation cycle patients after prolonged vaginal progesterone treatment
Phase: PHASE4 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Prevention
Last updated Jun 27, 2026 13:06 UTC
-
Can family bonds help teens beat HIV stigma?
Disease control CompletedThis study will evaluate the impact of Family Connections, a family-based group intervention for adolescents and young adults (AYA) living with HIV and their family caregivers, on achieving HIV self-management defined as having an undetectable viral load (VL) and low self-stigma …
Phase: NA • Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Sound waves zap kidney stones: no needle, no knife needed
Disease control Recruiting nowThis is a prospective, open-label, multi-center study to test the clinical feasibility of facilitating stone passage by the combination of breaking and repositioning stones with ultrasound, without the need for anesthesia.
Phase: NA • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Sham surgery showdown: is MALS release a real fix or just a myth?
Symptom relief Recruiting nowIn patients with Median Arcuate Ligament Syndrome (MALS), significant external compression of the coeliac artery (CA) by the median arcuate ligament (MAL) increasing mucosal ischemia (1,2) is assumed to cause chronic disabling postprandial abdominal pain, weight loss, and consequ…
Phase: NA • Sponsor: Medisch Spectrum Twente • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
New combo therapy shows promise for Tough-to-Treat endometrial cancer
Disease control OngoingThis phase Ib/II trial tests the safety, side effects, best dose, and effectiveness of the combination of ipatasertib with megestrol acetate to megestrol acetate alone in patients with endometrial cancer that has come back (recurrent) or has spread to other places in the body (me…
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Smartphone apps show promise for Schizophrenia's 'Negative' symptoms
Symptom relief CompletedThis study evaluates the efficacy of two prescription digital therapeutics (PDT) in addition to standard of care (SOC) therapy for the treatment of experiential negative symptoms of schizophrenia in late adolescents and adults.
Phase: PHASE3 • Sponsor: Click Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Zapping pancreatic tumors with heat: a new hope?
Disease control Recruiting nowThis is a single arm study in the treatment of pancreatic ductal adenocarcinoma (PDAC). The investigators propose to test the tolerability of chemotherapy plus endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) using the RF Electrode in patients receiving palliative s…
Phase: PHASE1 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New injection could ease swallowing for eosinophilic esophagitis patients
Disease control Recruiting nowA Phase 1b/2 study to explore the safety, efficacy and pharmacokinetics of EP-104GI in adults with eosinophilic esophagitis (EoE). Endoscopic and histologic assessments will also be evaluated to understand the local effects of EP-104GI on eosinophilic EoE disease activity. Approx…
Phase: PHASE1, PHASE2 • Sponsor: Eupraxia Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New gene therapy aims to tame PKU in first human test
Disease control Recruiting nowThis is a single-center, open-label, non-randomized, dose escalation study to evaluate the safety, tolerability and efficacy of NGGT002 in adult Phenylketonuria (PKU) subjects. All subjects will receive a single administration of NGGT002 and will be followed for safety and effica…
Phase: EARLY_PHASE1 • Sponsor: The First Affiliated Hospital of Bengbu Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Shockwave breakthrough opens door for heart valve fix in Hard-to-Treat patients
Symptom relief Recruiting nowTo assess the efficacy and safety of Intravascular Lithotripsy (IVL) in subjects undergoing transfemoral TAVR in patients with severe iliac disease, prohibitive for transfemoral TAVR in patients with severe symptomatic aortic stenosis, otherwise considered for alternative access …
Sponsor: Baylor Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Supplement epidiferphane aims to ease Chemo's harsh side effects
Symptom relief Recruiting nowPatients with breast cancer are commonly treated with taxane chemotherapy. Some very common side effects of taxanes, such as anemia and peripheral neuropathy, are often as not well addressed during treatment, resulting in dose reductions, dose delays and early discontinuation (co…
Phase: PHASE1, PHASE2 • Sponsor: University of Florida • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
New eye drops aim to speed vision recovery after cornea surgery
Disease control CompletedA study to assess the safety and efficacy of K-321 in participants with FECD after descemetorhexis.
Phase: PHASE3 • Sponsor: Kowa Research Institute, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Weight training cuts fall risk in 80+ seniors, study finds
Disease control OngoingThis study will investigate the effects of 12 months of high-intensity progressive resistance training compared with a control group on fall-rate in older adults with sarcopenia.
Phase: NA • Sponsor: Norwegian University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Eye blood flow camera could spot glaucoma before vision fades
Diagnosis Recruiting nowThe goal of this clinical trial is to investigate the use of an FDA-cleared retinal blood flow imaging instrument called the XyCAM RI and XyCAM FC (Vasoptic Medical, Inc., Columbia, MD) in glaucoma management. The main question it aims to answer are: * Can the investigators use…
Phase: NA • Sponsor: University of Maryland, Baltimore • Aim: Diagnosis
Last updated Jul 04, 2026 00:00 UTC